Entity Details

Primary name KCNK3_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO14649
EntryNameKCNK3_HUMAN
FullNamePotassium channel subfamily K member 3
TaxID9606
Evidenceevidence at protein level
Length394
SequenceStatuscomplete
DateCreated2001-02-21
DateModified2021-06-02

Ontological Relatives

GenesKCNK3

GO terms

Show/Hide Table
GOName
GO:0005216 ion channel activity
GO:0005252 open rectifier potassium channel activity
GO:0005267 potassium channel activity
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0006813 potassium ion transport
GO:0007268 chemical synaptic transmission
GO:0007420 brain development
GO:0008022 protein C-terminus binding
GO:0022841 potassium ion leak channel activity
GO:0030322 stabilization of membrane potential
GO:0034220 ion transmembrane transport
GO:0042493 response to drug
GO:0044548 S100 protein binding
GO:0045202 synapse
GO:0051481 negative regulation of cytosolic calcium ion concentration
GO:0061337 cardiac conduction
GO:0071294 cellular response to zinc ion
GO:0071456 cellular response to hypoxia
GO:0071805 potassium ion transmembrane transport
GO:0090102 cochlea development

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR003092 Two pore domain potassium channel, TASK familyFamilyFamily
IPR003280 Two pore domain potassium channelFamilyFamily
IPR005406 Potassium channel subfamily K member 3FamilyFamily
IPR013099 Potassium channel domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615344 OMIMPulmonary hypertension, primary, 4 (PPH4)A rare disorder characterized by plexiform lesions of proliferating endothelial cells in pulmonary arterioles. The lesions lead to elevated pulmonary arterial pression, right ventricular failure, and death. The disease can occur from infancy throughout life and it has a mean age at onset of 36 years. Penetrance is reduced. Although familial pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00561 DoxapramDrugbanksmall molecule
DB01159 HalothaneDrugbanksmall molecule